EUCTR2011-002775-42-AT
Active, not recruiting
Not Applicable
Vienna Interventional Management of Stroke Study
Med. Uni. Wien, UK für Neurologie0 sitesNovember 22, 2012
ConditionsAcute stroke
DrugsActilyse
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute stroke
- Sponsor
- Med. Uni. Wien, UK für Neurologie
- Status
- Active, not recruiting
- Last Updated
- 13 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 18 – 80 years
- •Clinical syndrome of a severe ischemic lesion within the anterior circulation („Total Anterior Circulation Syndrome TACS) or of basilar artery occlusion
- •NIHSS \> 12
- •Start of IVT within 3 hours („bridging, „rescue) or within 4\.5 hours (\`primary endovascular management\`)
- •Confirmation of proximal occlusion
- •Absence of exclusion criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 120
Exclusion Criteria
- •History of stroke within the last 3 months
- •History of subarachnoid or intracranial hemorrhage, known cerebrovascular arteriovenous malformation or CNS tumour
- •Clinical suggestion of subarachnoid hemorrhage and negative CT
- •Uncontrolled systolic blood pressure
- •Evidence of septic embolism etiologically related to stroke
- •Evidence of pericarditis including pericarditis after myocardial infarction
- •Operation or biopsy of a body organ within the last 30 days (not an exclusion criterion for primary endovascular treatment)
- •Trauma with inner or outer ulcerous wounds within the last 30 days (not an exclusion criterion for primary endovascular treatment)
- •Severe head trauma or concussion within the last 90 days
- •Current bleeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The clinical intervention trial to post stroke depression and apathyPost stroke depression and apathyJPRN-UMIN000008312Yuaikai Hospital200
Completed
Phase 3
INTERVENTIONAL MANAGEMENT OF STROKE TRIAL CLINICAL PROTOCOL - IMS III A phase III, randomized, multi-center, open label, 900 subject clinical trial that will examine whether a combined intravenous (IV) and intra-arterial (IA) approach to recanalization is superior to standard IV rt-PA (Activase®/Actilyse®) alone when initiated within three hours of acute ischemic stroke onset.ischemic cerebrovascular accidentStroke1000796310014523NL-OMON36365ational Institute of Health20
Active, not recruiting
Not Applicable
TERVENTIONAL MANAGEMENT OF STROKE TRIAL CLINICAL PROTOCOL (IMS III study)Ischemic StrokeMedDRA version: 14.0Level: PTClassification code 10065528Term: NIH stroke scale score increasedSystem Organ Class: 10022891 - InvestigationsMedDRA version: 14.0Level: LLTClassification code 10055221Term: Ischemic strokeSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2009-017454-12-DEniversity of Cincinnati - Academic Medical Center -Department of Neurology900
Active, not recruiting
Not Applicable
INTERVENTIONAL MANAGEMENT OF STROKE TRIAL CLINICAL PROTOCOL(IMS III study)Ischemic StrokeMedDRA version: 14.1Level: PTClassification code 10065528Term: NIH stroke scale score increasedSystem Organ Class: 10022891 - InvestigationsMedDRA version: 14.1Level: LLTClassification code 10055221Term: Ischemic strokeSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2009-017454-12-NLniversity of Cincinnati - Academic Medical Center -Department of Neurology900
Not yet recruiting
Not Applicable
The significance of serum uric acid in acute stroke.Health Condition 1: G969- Disorder of central nervous system, unspecifiedCTRI/2021/08/035792DR SAKSHI